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Abstract
Two honokiol dimers, houpulins A and B (1 and 2), and two magnolol derivatives, houpulins C and D (3 and 4), were isolated
and characterized from an ethanol extract obtained from the roots of Magnolia officinalis. The chemical structures were
determined based on spectroscopic and physicochemical analyses, which included 1D and 2D NMR, as well as mass
spectrometry data. These four oligomers possess new carbon skeletons postulated to be biosynthesized from the coupling
of three or four C6-C3 subunits. In addition, the new oligomers were evaluated for inhibition of superoxide anion generation
and elastase release, and houpulin B (2) was identified as a new anti-inflammatory lead compound.
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Introduction
Magnolia officinalis Rehd. et Wils. (Magnoliaceae) is called Hou-
pu in Chinese, and is a rare and endangered species listed under
Class II National Protection in China. It’s roots, stems, and
branches are used in traditional Chinese medicine for the
treatment of various disorders, such as depression coughing,
asthma, liver disease, shoulder pain, urinary problems, and
diarrhea [1], [2]. Neolignans, sesquiterpenes, sesquiterpene
neolignans [3], [4], [5], phenylpropanoids[6], [7] have been
identified from prior phytochemical studies of M. officinalis [4].
These constituents exhibit antimicrobial [8], [9], anticancer [10],
[11], [12], anti-epileptic [13], antitumor [3], antibacterial [14],
cytotoxic [6], and anti-inflammatory effects [7], [15], [16]. The
various oligomeric neolignans in the plant are linked through the
aromatic rings, including ortho, ortho (o,o)-linked dimers, (o,o)-linked
trimers, dimers and trimers with o,O-linkages, and o,o-/o,p-linked
trimers [17], [18], [19]. These neolignans have significant
potential as new anti-inflammatory lead drugs. However, the
chemical and biological studies of the Magnolia species have
focused mainly on the constituents obtained from the stems and
bark, because of the rareness of the roots. In the present work, we
investigated the ethanol extract obtained from the roots of M.
officinalis and reported two honokiol dimers and two magnolol
derivatives, as well as possible biogenetic pathways. In addition,
these isolates were examined for inhibition of superoxide anion




Blood was taken from healthy human donors (20–30 years old)
by venipuncture, using a protocol approved by the Institutional
Review Board at Chang Gung Memorial Hospital. All donors
gave written consent. The Medical Ethics Committee of Chang
Gung Memorial Hospital approved this consent procedure.
General experimental procedures
Optical rotations were measured using a JASCO DIP-370
digital polarimeter. IR spectra were obtained with a Shimadzu
FT-IR DR-8011 spectrophotometer. 1HNMR, 13C NMR, COSY,
HMQC, HSQC, HMBC and NOESY spectra were recorded on
Bruker AVANCE III-400 spectrometer. Chemical shifts are shown
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in d values (ppm) with tetramethylsilane as an internal standard.
Mass spectra were measured on Bruker APEXII spectrometer with
ESI ionization (positive-ion mode). Column chromatography was
performed in silica gel (70–230 mesh, 230–400 mesh), and PTLC
was executed on Merck pre-coated Si gel 60 F254 plates, using UV
light to visualize the spots.
Plant material
The root of M. officinalis was provided by Chuang Song-Zong
Pharmaceutical Factory and authenticated by Prof. C. S. Kuo,
Department of Life Science, National Cheng Kung University. A
voucher specimen (2010000013) has been deposited in the
Herbarium of National Cheng Kung University, Tainan, Taiwan.
Extraction and isolation
Dried and powdered roots of M. officinalis (5.0 kg) were refluxed
with ethanol (6620 L) and filtered. The filtrate was concentrated
to afford the crude extract (2.0 kg). The crude extract was
suspended in water and partitioned with dichloromethane. The
organic layers were combined and concentrated to yield a
dichloromethane extract (550.0 g). The dichloromethane extract
was further partitioned with 5% HCl aqueous solution to afford
dichloromethane solubles (440.0 g) and 5% HCl aqueous extract
(90.0 g). The dichloromethane solubles were subjected to open
column chromatography over silica gel by eluting with a mixture
of n-hexane and EtOAc (19:1) and stepwise gradient of EtOAc to
obtain 10 fractions. Fraction 6 was further purified by column
chromatography over silica gel with a mixed eluent of n-hexane
and acetone (4:1) followed by repeated column and thin-layer
chromatography to afford compounds 1 (17.4 mg) and 2
(14.7 mg). Similarly, repeated column chromatography, prepara-
tive thin-layer chromatography, and HPLC of fraction 7 yielded 3
(2.2 mg) and 4 (5.8 mg).
Houpulin A (1): brown syrup; [a]D
25 27.88 (c 0.83, MeOH);
IR (KBr) lmax 3502, 3390, 3078, 1639, 1604, 1504, 1465, 1226,
914, 756 cm21; 1H NMR: see Table 1; 13C NMR: see Table 1;
ESI-MS m/z: 553 ([M+Na]+); HR-ESI-MS m/z: 553.2357
([M+Na]+) (Calcd for C36H34O4Na, 553.2355).
Houpulin B (2): brown syrup; [a]D
25 27.98 (c 0.7, MeOH);
IR (KBr) lmax 3501, 3410, 3074, 1639, 1600, 1504, 1465, 1222,
914, 756 cm21; 1H NMR: see Table 1; 13C NMR: see Table 1;
ESI-MS m/z: 553 ([M+Na]+); HR-ESI-MS m/z: 553.2353
([M+Na]+) (Calcd for C36H34O4Na, 553.2355).
Houpulin C (3): brown gum; [a]D
25 265.74 (c 0.11, MeOH);
IR (KBr) lmax 3375, 3352, 2924, 1639, 1612, 1496, 1465, 1226,
914, 756 cm21; 1H NMR: see Table 1; 13C NMR: see Table 1;
ESI-MS m/z: 421 ([M+Na]+); HR-ESI-MS m/z: 421.1782
([M+Na]+) (Calcd for C27H26O3Na, 421.1780).
Houpulin D (4): brown syrup; [a]D
25 257.64 (c 0.23,
MeOH); IR (KBr) lmax 3356, 3340, 2924, 1697, 1608, 1496,
1465, 1226, 914, 756 cm21; 1H NMR: see Table 1; 13C NMR: see
Table 1; ESI-MS m/z: 553 ([M+Na]+); HR-ESI-MS m/z:
553.2352 ([M+Na]+) (Calcd for C36H34O4Na, 553.2355).
Preparation of human neutrophils
Blood was taken from healthy human donors (20–30 years old)
by venipuncture, using a protocol approved by the Institutional
Review Board at Chang Gung Memorial Hospital. All donors
gave written consent. The Medical Ethics Committee of Chang
Gung Memorial Hospital approved this consent procedure.
Neutrophils were isolated with a standard method of dextran
sedimentation prior to centrifugation in a Ficoll Hypaque gradient
and hypotonic lysis of erythrocytes. Purified neutrophils that
contained .98% viable cells, as determined by the trypan blue
exclusion method, were re-suspended in calcium (Ca2+)-free HBSS




2 generation assay was based on the SOD-inhibitable
reduction of ferricytochrome c. In brief, after supplementation
with 0.5 mg/mL ferricytochrome c and 1 mM Ca2+, neutrophils
(66105 cells/mL) were equilibrated at 37uC for 2 min and
incubated with test compound or an equal volume of vehicle (0.1%
DMSO) for 5 min. Cells were activated with 100 nM FMLP
during the preincubation of 1 mg/mL cytochalasin B (FMLP/
cytochalasin B) for 3 min. Changes in the absorbance with a
reduction in ferricytochrome c at 550 nm were continuously
monitored in a double-beam, six-cell positioner spectrophotometer
with constant stirring (Hitachi U-3010, Tokyo, Japan).
Measurement of elastase release
Degranulation of azurophilic granules was determined by
elastase release as described previously. Experiments were
performed using MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide as the
elastase substrate. Briefly, after supplementation with MeO-Suc-
Ala-Ala-Pro-Val-p-nitroanilide (100 mM), neutrophils (66105/ml)
were equilibrated at 37uC for 2 min and incubated with test
compound or an equal volume of vehicle (0.1% DMSO) for
5 min. Cells were activated by 100 nM FMLP and 0.5 mg/mL
cytochalasin B, and changes in absorbance at 405 nm were
continuously monitored to assay elastase release. The results were
expressed as the percent of elastase release in the FMLP/
cytochalasin B-activated, drug-free control system.
Statistical analysis
Results were expressed as mean 6 S.E.M. Computation of 50%
inhibitory concentration (IC50) was computer-assisted (PHARM/
PCS v.4.2). Statistical comparisons were made between groups
using Student’s t test. Values of P less than 0.05 were considered to
be statistically significant.
Results
Characterization of new compounds
Repeated silica gel and RP-C18 column chromatography of the
dichloromethane-soluble fraction from the ethanol extract ob-
tained from the roots of M. officinalis afforded four novel oligomeric
neolignans (1–4) with new carbon skeletons. Compound 1 was
obtained as optically active syrup. The positive-mode HR-ESI-MS
of 1 showed a sodiated molecular ion peak at m/z 553.2357
([M+Na]+), corresponding to a molecular formula of C36H34O4
with 20 indices of hydrogen deficiency (IHD). The absorption
bands in the IR spectrum indicated the presence of hydroxy
(3502 cm21) and phenyl groups (1639 and 1504 cm21). Analysis
of the 13C NMR, DEPT135 and HMQC spectral data identified
36 carbon signals consistent with four oxygenated quaternary
aromatic carbons at d 155.2, 153.3, 151.9, and 149.6; eleven
tertiary aromatic carbons at d 132.0, 131.4, 131.4, 131.4, 131.3,
131.1, 131.0, 129.4, 128.9, 117.0 and 115.8; nine quaternary
aromatic carbons at d 133.2, 132.2, 131.8, 130.6, 129.1, 128.6,
127.6, 127.2, and 126.9; eight olefinic carbons at d 139.3, 139.1,
138.1, 138.0, 115.8, 115.7, 115.6, and 115.5; and four aliphatic
methylene carbons at d 40.1, 40.1, 35.6, and 35.1. The 1H NMR
spectrum of 1 displayed two sets of ABX-type aromatic signals at d
6.88 (1H, d, J = 8.1 Hz, H-5), 7.00 (1H, dd, J = 8.1, 2.2 Hz, H-6),
and 7.13 (1H, d, J = 2.2 Hz, H-2), as well as 6.91 (1H, d,
J = 8.1 Hz, H-590), 7.28 (1H, dd, J = 8.1, 2.1 Hz, H-490), and 7.32
(1H, d, J = 2.1 Hz, H-290). In addition, there were two sets of meta-
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coupled aromatic protons at d 7.09 (1H, brs, H-20) and 7.09 (1H,
brs, H-60) and 7.36 (1H, d, J = 2.2 Hz, H-49) and 7.37 (1H, d,
J = 2.2 Hz, H-69). Based on the 1H-1H COSY spectrum, four sets
of allyl groups were found at d 3.34 (2H, d, J = 6.7 Hz, H-7), 5.96
(1H, m, H-8), and 5.00 (2H, m, H-9); 3.51 (2H, d, J = 6.7 Hz, H-
79), 6.10 (1H, m, H-89), and 5.14 (2H, m, H-99); 3.39 (2H, d,
J = 6.9 Hz, H-70), 6.00 (1H, m, H-80), and 5.03 (2H, m, H-90); and
3.43 (2H, d, J = 6.7 Hz, H-790), 6.04 (1H, m, H-890), and 5.08 (2H,
m, H-990). From the above spectroscopic data and the proposed
biomimetic synthesis in prior studies [17], [18], [19], the chemical
structure of 1 should be an o,o-/o,p-linked tetramer containing four
C6-C3 subunits (moieties A–D shown in Figure 1). The connec-
tions of these moieties were further elucidated via 2D-correlational
techniques, including HMBC and NOESY analyses. In the
HMBC spectrum, 2J, 3J-correlations from d 3.34 (H-7) to d
128.9 (C-6), 131.4 (C-2), and 132.2 (C-1), from d 3.51 (H-79) to d
128.6 (C-19), 131.1 (C-69), and 151.9 (C-29), and from d 6.88(H-5),
7.36 (H-49), and 7.37 (H-69) to d 129.1 (C-3) indicated that
Table 1. 1H and 13C Spectroscopic Data of 1–4.
1a 2a 3 b 4 a
position dH mult. (J, Hz) dC dH mult. (J, Hz) dC dH mult. (J, Hz) dC dH mult. (J, Hz) dC
1 132.2 132.1 132.1 131.7
2 7.13 d (2.2) 131.4 7.12 d (2.2) 131.2 7.08 d (2.4) 131.3 7.03 d (2.2) 132.4
3 129.1 128.9 126.6 127.1
4 153.3 153.2 152.1 153.8
5 6.88 d (8.1) 117.0 6.88 d (8.2) 116.9 6.88 d (8.3) 117.5 6.80 d (8.18) 117.1
6 7.00 dd (8.1, 2.2 ) 128.9 6.97 dd (8.2, 2.2 ) 128.8 7.09 dd (8.3, 2.4 ) 129.1 6.96 dd (2.2, 8.18) 129.3
7 3.34 d ( 6.7) 40.1 3.33 d (6.7) 40.0 3.34 brd 39.5 3.23 d (6.7) 40.0
8 5.96 m 139.3 5.96 m 139.2 5.04 m 137.9 6.00 m 139.2
9 5.00 m 115.5 5.02 m 115.4 5.95 m 115.7 4.98 m 115.4
1’ 128.6 128.5 132.9 132.5
2’ 151.9 7.37 brs 131.4 6.99 brs 130.5 6.95 brs 130.6
3’ 127.6 7.37 brs 126.1 126.4 127.8
4’ 7.36 d (2.2) 131.3 131.2 149.6 151.5
5’ 131.0 131.7 122.3 123.2
6’ 7.37 d (2.2) 131.1 151.7 6.96 brs 129.4 6.95brs 129.8
7’ 3.51 d (6.7) 35.6 35.4 3.36 brd 39.4 40.9
8’ 6.10 m 138.0 137.9 5.11 m 137.6 139.2
9’ 5.14 m 115.8 115.8 6.00 m 115.7 115.6
1’’ 133.2 132.8 134.8
2’’ 7.09 brs 131.4 7.20 d (8.69) 127.4 7.35 d (2.1) 130.3
3’’ 131.8 6.70 d (8.69) 115.4 127.1
4’’ 149.6 155.4 154.4
5’’ 126.9 6.70 d (8.69) 115.4 6.94 d (8.1) 117.4
6’’ 7.09 brs 131.4 7.20 d (8.69) 127.4 7.32 dd (8.1, 2.1 ) 127.4
7’’ 3.39 d (7.0) 40.1 5.07 m 78.5 5.12 m 78.7
8’’ 6.00 m 139.1 a: 2.25 m
b: 2.15 m
29.4 a: 2.29 m
b: 2.10 m
30.6
9’’ 5.03 m 115.6 a: 3.04 m
b: 2.89 m




2’’’ 7.32 d (2.1) 132.0 7.09 d (1.8) 132.7
3’’’ 130.6 127.1
4’’’ 7.28 dd (2.1, 8.1) 129.4 153.1
5’’’ 6.91 d (8.1) 115.8 6.92 d (8.1) 117.4
6’’’ 155.2 7.05 dd (8.1, 1.8) 129.7
7’’’ 3.43 d (6.7) 35.1 3.37 d (7.6) 40.1
8’’’ 6.04 m 138.1 5.90 m 139.1
9’’’ 5.08 m 115.7 5.03 m 115.5
a: d (ppm); 400 MHz for 1H and 100 MHz for 13C; acetone-d6; J values (Hz) in parentheses.
b: d (ppm); 500 MHz for 1H and 125 MHz for 13C; CDCl3; J values (Hz) in parentheses.
doi:10.1371/journal.pone.0059502.t001
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subunits A and B were linked through C-3/C-59 similarly to
honokiol. In addition, the long range HMBC cross-peaks from d
3.39 (H-70) to d 131.4 (C-20), 131.4 (C-60), and 133.2 (C-10); from
d 3.43 (H-790) to d 127.2 (C-190), 132.0 (C-290) and 155.2 (C-690);
from d 7.28 (H-490) to d 131.8 (C-30); and from d 7.09 (H-20) to d
130.6(C-390) revealed that subunits C and D were also connected
similarly to honokiol. The NOE correlations of H-2/H-7, H-7/H-
6, OH-4/H-5 in subunit A; H-69/H-79 in subunit B; H-20/H-70,
H-70/H-60 in subunit C; H-290/H-790, OH-690/H-590 in subunit
D; H-2/H-49 between subunits A and B; and H-49/H-60 between
subunits B and C established the connectivity of the two honokiol
fragments to be C-39/C-50, and the structure of 1 was determined
conclusively, as shown in Figure 1. Compound 1 was named
houpulin A.
The positive-mode HR-ESI-MS of compound 2 displayed a
sodiated molecular ion peak at m/z 553.2353 ([M+Na]+) consistent
with a molecular formula of C36H34O4 with 20 degrees of
unsaturation, as also found in 1. The UV absorption maxima and
IR absorption bands of 2 were very similar to those of 1. The 1H
NMR spectrum of 2 exhibited symmetric proton signals including
one set of ABX-type aromatic signals, two overlapped meta-
coupled signals, and two allyl groups. The HMBC correlations
from d 7.37 (H-69) to d 126.1 (C-59), 128.9 (C-3), 131.2 (C-49), and
151.7 (C-29); from d 3.53 (H-79) to d 128.5 (C-19), 131.4 (C-69),
and 151.7 (C-29); and from d 3.33 (H-7) to d 128.8 (C-6) and 131.2
(C-2) supported the presence of a C-3/C-59 linkage between
subunits A and B, as also found in 1. However, a comparison of
the proton and carbon NMR spectra of 2 with those of 1 suggested
that the two honokiol moieties in 2 are connected symmetrically.
Thus, the two honokiol fragments are connected between C-39
and C-30, rather than C-39 and C-50. Therefore, the structure of 2
was elucidated as shown in Figure 1, and the compound has been
named houpulin B.
Figure 2 depicts our proposed biogenetic pathway to com-
pounds 1 and 2, with the compounds being derived by
bimolecular coupling between two honokiol radical derivatives.
Because the radical intermediate would be more stable if the
radical was located at the ortho-position to the hydroxy group, the
major honokiol radical intermediates are 5 and 6, and the
resultant coupling products are compounds 1 and 2, which exhibit
the new carbon skeletons characterized in the present work.
Compound 3 was purified as an optically active gum with a
molecular formula of C27H26O3, which was deduced by HR-ESI-
MS analysis. The IR absorption bands at 3375, 1612, and
1496 cm-1 indicated the presence of hydroxy and phenyl groups in
3. The 1H NMR spectrum of 3 exhibited ABX-type aromatic
Figure 1. Structures of 1–4.
doi:10.1371/journal.pone.0059502.g001
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signals at d 6.88 (1H, d, J = 8.3 Hz, H-5), 7.08 (1H, d, J = 2.2 Hz,
H-2), and 7.09 (1H, dd, J = 8.3, 2.2 Hz, H-6); one set of A2B2
signals at d 6.70 (2H, d, J = 8.7 Hz, H-20) and 7.20 (2H, d,
J = 8.7 Hz, H-30); one set of meta-coupled signals at d 6.96 (1H, br
s, H-69) and 6.99 (1H, br s, H-29); and two allyl groups at d 3.34
(2H, brd, H-7), 5.95 (1H, m, H-8), 5.04 (2H, m, H-9), and 3.36
(2H, brd, H-79), 6.00 (1H, m, H-89), 5.11 (2H, m, H-99). In
addition, there were five aliphatic proton signals at d 5.07 (1H, m,
H-70), 2.25 (1H, m, Ha-80), 2.15 (1H, m, Hb-80), 3.04 (1H, m, Ha-
90) and 2.89 (1H, m, Hb-90). The
13C-, DEPT-135, and HSQC
NMR spectra revealed 27 carbon signals, three oxygenated
quaternary aromatic carbons at d 149.6, 152.1, and 155.4; nine
tertiary aromatic carbons at d 115.4, 115.4, 117.5, 127.4, 127.4,
129.1, 129.4, 130.5, and 131.1; nine quaternary aromatic carbons
at d 122.3, 126.4, 126.6, 132.2, 132.8, 132.9, 149.6, 152.1, and
155.4; four olefinic carbons at d 137.9, 137.6, 115.7, and 115.7;
one oxygenated aliphatic carbon at d 78.5; and four methylene
aliphatic carbons at d 25.2, 29.4, 39.4, and 39.5. These
spectroscopic data suggested the presence of two neolignan
moieties (IHD = 10) and one p-disubstituted benzene ring
(IHD = 4), which leaves one degree of unsaturation. In the HMBC
spectrum, the long-range correlations from d 6.88 (H-5) to d 126.6
(C-3), 132.2(C-1), and 152.1 (C-4); from d 6.99 (1H, br s, H-29) to
d 39.4 (C-79), 126.6 (C-3), and 149.6 (C-49); and from d 5.07 (1H,
m, H-70) to d 127.4 (C-20 and C-60) indicated that subunits A and
B were linked through C-3/C-39 similarly to magnolol and that
subunit C was attached to subunit B between C-49 and C-59 to
form a dihydrobenzopyran ring. In the NOESY spectrum of 3, the
cross-peaks corresponding to H-7/H-2 and H-6; H-79/H-29 and
H-69; H-69/H-90; and H-70/H-20 and H-60 allowed for the
complete assignment of the proton and carbon signals. Further-
more, compound 3 displayed a negative Cotton effect at 280 nm
[20], [21] in the CD spectrum. Therefore, the absolute
configuration at C-70 was assigned as S. The structure of 3 was
elucidated as shown in Figure 1, and the compound given the
name houpulin C.
Compound 4 was obtained as optically active syrup with a
molecular formula of C36H34O4, which was determined by a
pseudomolecular ion peak at m/z 553.2352 in the HR-ESI-MS
analysis. The IR spectrum displayed absorption bands at 3356,
1608, and 1496 cm21, which are consistent with the presence of
hydroxy and benzyl functionalities, respectively. The 1H NMR
spectrum of 4 exhibited three sets of ABX-type aromatic signals,
three sets of allyl groups, one set of meta-coupled protons, and five
aliphatic protons, which were very similar to those of compound 3.
From the MS and NMR (13C, DEPT135, and HSQC) data, one
additional C6-C3 subunit was present in compound 4. This
postulation was further corroborated by HMBC analysis. In the
HMBC spectrum of 4, 2J, 3J-correlations from d 7.03 (H-2) to d
127.8 (C-39) and from d 6.95 (H-29) to d 127.1 (C-3) established
the C-3/C-39 connectivity of subunits A and B; correlations from d
5.12 (H-70) to d 130.3 (C-20) and 134.8 (C-10) indicated the
formation of a dihydrobenzopyran subunit C connected to subunit
B at C-49 and C-59; and finally, correlations from d 7.35 (H-20) to
d 127.1 (C-390) and from d 7.09 (H-290) to d 127.1 (C-30) showed
Figure 2. Plausible biosynthetic pathway to 1 and 2.
doi:10.1371/journal.pone.0059502.g002
Table 2. Inhibitory effects of 1–4 on superoxide anion












aConcentration necessary for 50% inhibition. Results are presented as the mean
6 S.D. (n = 3).
***P,0.001 compared with the control value.
bAlone induced superoxide generation by human neutrophils.
cSorafenib, a tyrosine kinase inhibitor, was used as a positive control.
doi:10.1371/journal.pone.0059502.t002
Figure 3. Compound 2 did not alter activation of ERK, p38
MAPK, JNK, and Akt.
doi:10.1371/journal.pone.0059502.g003
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that the fourth C6-C3 subunit was attached at the C-30 position of
subunit C. The NOESY cross-peaks corresponding to H-79/H-69
and H-69/H-90 as well as H-70/H-20 and H-60 confirmed the
connectivities of subunits B and C, as well as subunits C and D,
respectively. Furthermore, the stereochemical configuration at C-
70 of compound 4 was assigned as R based on a positive Cotton
effect at 280 nm [20], [21] observed in the CD spectrum.
Consequently, the structure of 4 (Figure 1) was established
unambiguously, and the compound has been named houpulin D.
Biological results
Compounds 1–4 were evaluated for inhibition of superoxide
anion generation and elastase release by human neutrophils in
response to FMLP/cytochalasin B [22], and the data are shown in
Table 2. Compounds 1, 2, and 4 inhibited superoxide anion
generation and elastase release in FMLP/cytochalasin B activated
human neutrophils in a concentration-dependent manner. Al-
though compound 3 significantly inhibited elastase release with an
IC50 value of 3.4060.53 mM, it also induced superoxide
generation by human neutrophils. Among the tested compounds,
compound 2 demonstrated the most significant inhibition towards
superoxide anion generation and elastase release with IC50 values
of 2.8560.16 and 2.0060.50 mM, respectively, compared with the
reference compound sorafenib (IC50 of 3.2360.42 and
2.0160.13 mM for inhibition of superoxide anion generation
and elastase release, respectively).
The anti-neutrophilic effect of compound 2 was further
evaluated in preliminary mechanistic studies. Compound 2 did
not alter activation of ERK, p38 MAPK, JNK, or Akt (Figure 3).
Notably, compound 2 failed to alter the peak [Ca2+]i values in
FMLP-induced cells, but the time it took for [Ca2+]i to return to
half of the peak value (t1/2) was significantly shortened by
compound 2 (Figure 4). Many neutrophil functions, such as
respiratory burst and degranulation, are regulated by calcium
signals; thus, calcium clearance mechanisms are increasingly
viewed as novel targets for pharmacological control of neutrophilic
inflammation [23]. Compound 2 merits further investigation and
development as an anti-inflammatory clinical trial candidate.
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